Skip to content
Free shipping over $200FedEx 2-day shipping
Routine Peptides
HPLC tested
Representative HPLCPer lot
Ipamorelin research vial

Growth Hormone

Ipamorelin

GH Pulse Studies

Third-party testedCOA per lotView COA · 99.51%
$9610mg · $9.60/mg

Quantity

1

Ships from the United States with tracking · free shipping over $200

PassedSterility & Endotoxins
PassedNet Content & Purity
Research use only
Third-party tested
COA with every lot
Tracked shipping

Researchers also added

CJC-1295 DAC

5mg

$72.00

CJC / IPA Blend

10mg

$120.00

IGF-1 LR3

1mg

$84.00

Authenticity

Every vial carries a code

Scan the code on the label to pull up every published certificate for that compound — the same reports the third-party laboratory issued, batch by batch. Traceable from the laboratory that tested it to your bench.

Verify a batch →

Verified, lot by lot

Per lot
  • Independently tested

    Purity is quantified by reverse-phase HPLC and identity confirmed by mass spectrometry, by an outside laboratory rather than in-house.

  • A certificate for your lot

    The report that ships with your order describes the batch you received — not the product line, and not a representative sample.

  • COA-backed replacement

    If material does not match the certificate issued for its lot, we replace it or refund it. Send us the lot number and we will trace it.

  • Tracked dispatch

    Tracking is issued when the label is created, so the shipment is traceable from the moment it leaves us.

🎯
0%
Cortisol Elevation
No stress hormone activation vs GHRP-6
80 nmol/kg
GH Release ED50
Dose-dependent GH secretion in vivo
⏱️
2 hr
Half-Life
Peak GH release at ~40 min post-dose
🎯
4
Research Areas
Selective GH Secretagogue · GH Secretion & Sleep · Bone Growth Models & more

About this compound

What Ipamorelin is

C38H49N9O5

Ipamorelin is a five-residue peptide binding GHS-R, the growth hormone secretagogue receptor. It is studied specifically for its selectivity: unlike earlier secretagogues, published work reports minimal effect on cortisol and prolactin at comparable doses, which is why it appears so often in growth-hormone pulse research.

Formula
C38H49N9O5
Molecular weight
711.85 g/mol
Form
Lyophilized Powder
CAS / ID
170851-70-4
Read the full Ipamorelin research monograph →

Full specification

Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Molecular weight
711.90 g/mol
Physical form
Lyophilized powder
Documented purity
Quantified by HPLC, reported per lot
Storage
-20°C for up to 24 months
Solubility
Water-soluble

How it works

How Ipamorelin works

The pathways Ipamorelin acts on, and what each one does. Signalling described from preclinical models.

Ghrelin Receptor Activation

GHSR-1a Agonist

Binding is selective for GHSR-1a on anterior pituitary somatotrophs, which is the receptor population that releases growth hormone. Selectivity at that site is the compound's defining property.

  • Selective for GHSR-1a
  • Dose-dependent release, ED50 80 nmol/kg
  • No desensitisation with repeated administration

No Cortisol or Prolactin Elevation

Selectivity

At doses producing substantial growth hormone release, published work reports no meaningful rise in ACTH, cortisol or prolactin — the off-target effects that limited earlier secretagogues in the same class.

  • ACTH and cortisol unchanged, unlike GHRP-6
  • No meaningful prolactin rise
  • Selectivity at the pituitary is the defining property

Physiologic GH Secretion Pattern

Pulsatile GH

Release occurs in discrete bursts rather than as a sustained elevation, matching the pattern of endogenous secretion. Whether pulse shape matters as much as total exposure is an open question the literature keeps returning to.

  • Pulsatile pattern preserved
  • Peak response around 40 minutes post-dose
  • Additive when paired with a GHRH analogue

Uses & applications

What Ipamorelin is researched for

The main areas under study, and the study-reported figures behind them.

Endocrinology

Selective GH Secretagogue

Selectivity is the property under study: growth hormone release without the cortisol and prolactin rise earlier secretagogues produced.

Raun et al. 1998

Sleep Research

GH Secretion & Sleep

Endogenous release peaks during slow-wave sleep, so sleep-phase dosing is a recurring variable in the protocols.

Frieboes et al. 2004

Musculoskeletal

Bone Growth Models

Bone mineral density and longitudinal growth are measured in rodent models as downstream consequences of altered release.

Raun et al. 1998

Combination Research

Synergy with GHRH Analogs

Combination work tests whether engaging the ghrelin and GHRH receptors together amplifies the pulse beyond either alone.

Raun et al. 1998

What the published work measures

The endpoints reported across the literature for this compound. The figures belong to the individual papers, not to us.

  • GH Release vs GHRP-6 (equal dose)
  • Cortisol Elevation (vs GHRP-6)
  • Bone Growth Rate Increase (rat model)
  • GH Release Duration Post-Dose

Molecular structure

The Ipamorelin molecule

A computed low-energy conformer built from this compound's published connectivity and stereochemistry, paired with its verified reference values.

Drag to rotate

101 atoms

CONH

101 atoms, 104 bonds, C38H49N9O5. Connectivity and stereochemistry from PubChem CID 9831659. The arrangement is one computed low-energy conformer, not a measured structure — a flexible peptide adopts many conformations in solution.

C38H49N9O5

Molecular formula
C38H49N9O5
Molecular weight
711.85 g/mol
Sequence length
5 residues
CAS / ID
170851-70-4
Physical form
Lyophilized Powder
Documented purity
Quantified by HPLC, reported per lot

Third-party verified

Independently tested, lot by lot.

Every batch of Ipamorelin is sent to an accredited independent laboratory before it ships. Here is what we screen for.

HPLC purity analysis

Quantifies purity and reports it on the lot certificate

Mass spectrometry

Verifies the exact molecular identity

Heavy metals screening

Lead, arsenic, cadmium & mercury

Endotoxins (LAL)

Bacterial endotoxin levels

Sterility testing

No microbial contamination

Net peptide content

Actual peptide mass per vial verified

FAQ

Common questions about Ipamorelin

What is Ipamorelin?

+

Ipamorelin is a five-residue peptide binding GHS-R, the growth hormone secretagogue receptor. It is studied specifically for its selectivity: unlike earlier secretagogues, published work reports minimal effect on cortisol and prolactin at comparable doses, which is why it appears so often in growth-hormone pulse research.

What is Ipamorelin researched for?

+

Published research on Ipamorelin concentrates on Selective GH Secretagogue, GH Secretion & Sleep, Bone Growth Models and Synergy with GHRH Analogs. Each of those areas is summarised further up this page with the citation it comes from, and the full reference list — 4 indexed publications — sits at the bottom. Study designs and concentrations vary considerably between publications, so the primary sources are worth reading directly.

How does Ipamorelin work?

+

The literature describes Ipamorelin acting across Ghrelin Receptor Activation, No Cortisol or Prolactin Elevation and Physiologic GH Secretion Pattern, reported respectively as GHSR-1a Agonist, Selectivity and Pulsatile GH. Those pathways are drawn from preclinical models rather than clinical work, and they describe what has been observed rather than a settled mechanism — the individual pathway cards above cite what each one is based on.

What are the molecular specifications for Ipamorelin?

+

Ipamorelin has a molecular formula of C38H49N9O5, an average mass of 711.85 g/mol and the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂. It is indexed under CAS 170851-70-4. It ships as lyophilized powder. Those are nominal reference values for the parent compound. The identity of the specific material you receive is confirmed by mass spectrometry and reported on that lot's certificate.

How should Ipamorelin be stored and reconstituted?

+

Store the sealed vial at -20°C, protected from light and moisture, and let it reach room temperature before opening so condensation does not form on cold powder. Ipamorelin is water-soluble; reconstitute by directing the diluent down the vial wall rather than onto the powder, then swirl to dissolve rather than shaking. Keep reconstituted solution refrigerated and avoid repeated freeze-thaw cycles — solutions are far less stable than lyophilized powder.

Is Ipamorelin approved for human use?

+

No. Ipamorelin is supplied strictly for in-vitro laboratory research and development. It is not a drug, food, supplement or cosmetic, it has not been evaluated by the FDA, and it is not intended for human or animal consumption, ingestion, injection or any in-vivo use. Ordering confirms you are a qualified researcher or institution purchasing on that basis.

Cited sources

Peer-reviewed literature

Independent published research indexed from PubMed and peer-reviewed journals — not Routine Peptides claims.

  1. [1]PubMedIpamorelin, the first selective growth hormone secretagogue (opens in a new tab)1998 — Raun K et al. (Novo Nordisk)View source →
  2. [2]PubMedGrowth hormone-releasing peptides stimulate GH secretion in human subjects during nocturnal sleep (opens in a new tab)2004 — Frieboes RM et al.View source →
  3. [3]PubMedGhrelin and growth hormone secretagogue receptors: functional characterization (opens in a new tab)2001 — Kojima M, Kangawa K et al.View source →
  4. [4]PubMedGHRP-2 vs ipamorelin: cortisol and GH secretion profiles in healthy men (opens in a new tab)2000 — Arvat E et al.View source →

For research use only

Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.

Before you order

Quality Becomes RoutineMeasured. Verified. Documented.

Every production run is analyzed by an independent laboratory, and the certificate for your lot travels with the order — not a catalog-wide document, and not a summary written by us.